Page last updated: 2024-08-24

imiquimod and Keratoacanthoma

imiquimod has been researched along with Keratoacanthoma in 18 studies

Research

Studies (18)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	8 (44.44)	29.6817
2010's	8 (44.44)	24.3611
2020's	2 (11.11)	2.80

Authors

Authors	Studies
Cho, KH; Choi, CW; Jo, SJ; Lee, JW	1
Wang, Y; Zhu, P	1
Apalla, Z; Chasioti, V; Lallas, A; Lefaki, I; Sidiropoulos, T; Tsikeloudi, M	1
Campalani, E; Holden, CA	1
Chitwood, K; Cohen, G; Etzkorn, J	1
Macknet, C; Macknet, KD; Nino, T; Panther, D	1
Chang, SE; Lee, MW; Lee, YJ; Rhee, do Y; Won, CH; Won, KH	1
Campione, E; Chimenti, S; Diluvio, L; Orlandi, A; Paternò, EJ	1
French, LE; Hofbauer, GF; Koch, S; Läuchli, S; Pini, AM; Schärer, L	1
Delaney, T; Foxton, G	1
Barysch, MJ; Dummer, R; Kamarashev, J; Lockwood, LL	1
Bartoli, L; Brunetti, L; Cecchi, R; Pavesi, M	1
Albertini, G; Di Lernia, V; Ricci, C	1
Huntley, A; Navi, D	1
Denkler, K; Kivett, WF	1
Carrington, PR; D'Addario, S	1
Dixon, A	1
Agrogiannis, G; Aroni, K; Ioannidis, E; Mastoraki, A; Patsouris, E	1

Reviews

2 review(s) available for imiquimod and Keratoacanthoma

Article	Year
Topical and intralesional treatment of nonmelanoma skin cancer: efficacy and cost comparisons. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2013, Volume: 39, Issue:9 Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Bleomycin; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Imiquimod; Injections, Intralesional; Interferon alpha-2; Interferon-alpha; Keratoacanthoma; Methotrexate; Recombinant Proteins; Skin Neoplasms	2013
Imiquimod 5 percent cream and the treatment of cutaneous malignancy. Dermatology online journal, 2004, Jul-15, Volume: 10, Issue:1 Topics: Aminoquinolines; Antineoplastic Agents; Apoptosis; Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cell Line, Tumor; Clinical Trials as Topic; Condylomata Acuminata; Drug Screening Assays, Antitumor; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Immunity, Cellular; Immunologic Factors; Keratoacanthoma; Keratosis; Male; Melanoma; Multicenter Studies as Topic; Mycosis Fungoides; Ointments; Paget Disease, Extramammary; Precancerous Conditions; Randomized Controlled Trials as Topic; Skin Neoplasms	2004

Article

Year

Topical and intralesional treatment of nonmelanoma skin cancer: efficacy and cost comparisons.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2013, Volume: 39, Issue:9

Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Bleomycin; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Imiquimod; Injections, Intralesional; Interferon alpha-2; Interferon-alpha; Keratoacanthoma; Methotrexate; Recombinant Proteins; Skin Neoplasms

2013

Imiquimod 5 percent cream and the treatment of cutaneous malignancy.

Dermatology online journal, 2004, Jul-15, Volume: 10, Issue:1

Topics: Aminoquinolines; Antineoplastic Agents; Apoptosis; Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cell Line, Tumor; Clinical Trials as Topic; Condylomata Acuminata; Drug Screening Assays, Antitumor; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Immunity, Cellular; Immunologic Factors; Keratoacanthoma; Keratosis; Male; Melanoma; Multicenter Studies as Topic; Mycosis Fungoides; Ointments; Paget Disease, Extramammary; Precancerous Conditions; Randomized Controlled Trials as Topic; Skin Neoplasms

2004

Other Studies

16 other study(ies) available for imiquimod and Keratoacanthoma

Article	Year
Therapeutic efficacy of topical imiquimod cream on keratoacanthoma: A retrospective single-center study. Journal of the American Academy of Dermatology, 2022, Volume: 87, Issue:3 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Humans; Imiquimod; Keratoacanthoma; Retrospective Studies; Skin Neoplasms; Treatment Outcome	2022
Multiple keratoacanthomas in a patient with myelodysplastic syndrome. The Lancet. Haematology, 2021, Volume: 8, Issue:1 Topics: Aclarubicin; Administration, Topical; Antineoplastic Agents; Azacitidine; Carcinoma; Female; Humans; Imiquimod; Keratoacanthoma; Middle Aged; Myelodysplastic Syndromes	2021
Imiquimod as neoadjuvant treatment for giant keratoacanthoma arising on a background of lupus vulgaris. Clinical and experimental dermatology, 2014, Volume: 39, Issue:1 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Chemotherapy, Adjuvant; Facial Dermatoses; Humans; Imiquimod; Keratoacanthoma; Lupus Vulgaris; Male; Treatment Outcome	2014
Keratoacanthoma associated with the use of topical imiquimod. Clinical and experimental dermatology, 2013, Volume: 38, Issue:5 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Humans; Imiquimod; Keratoacanthoma; Male; Middle Aged	2013
Eruptive keratoacanthomas as a complication of fractionated CO2 laser resurfacing and combination therapy with imiquimod and intralesional methotrexate. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2015, Volume: 41, Issue:1 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Imiquimod; Injections, Intralesional; Keratoacanthoma; Lasers, Gas; Methotrexate; Rejuvenation; Skin Neoplasms	2015
Successful treatment of multiple vemurafenib-induced keratoacanthomas by topical application of imiquimod cream: Confirmation of clinical clearance by dermoscopy. The Journal of dermatological treatment, 2016, Volume: 27, Issue:5 Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Drug Eruptions; Female; Humans; Imiquimod; Indoles; Keratoacanthoma; Melanoma; Skin Neoplasms; Sulfonamides; Treatment Outcome; Vemurafenib	2016
Imiquimod for restoring local immunity in a renal transplant patient with persistent keratoacanthoma. Dermatology online journal, 2008, Mar-15, Volume: 14, Issue:3 Topics: Adjuvants, Immunologic; Aminoquinolines; Humans; Imiquimod; Immunocompromised Host; Keratoacanthoma; Kidney Transplantation; Male; Middle Aged; Skin; Skin Neoplasms	2008
Eruptive keratoacanthoma following topical imiquimod for in situ squamous cell carcinoma of the skin in a renal transplant recipient. Journal of the American Academy of Dermatology, 2008, Volume: 59, Issue:5 Suppl Topics: Aged, 80 and over; Aminoquinolines; Bowen's Disease; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Keratoacanthoma; Keratosis, Actinic; Kidney Transplantation; Skin Neoplasms	2008
Eruptive keratoacanthoma and squamous cell carcinoma complicating imiquimod therapy: response to oral acitretin. The Australasian journal of dermatology, 2011, Volume: 52, Issue:1 Topics: Acitretin; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Keratoacanthoma; Keratolytic Agents; Skin Neoplasms; Treatment Outcome	2011
Successful treatment of multiple keratoacanthoma with topical imiquimod and low-dose acitretin. The Journal of dermatology, 2011, Volume: 38, Issue:4 Topics: Acitretin; Administration, Oral; Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Keratoacanthoma; Keratolytic Agents; Skin Neoplasms	2011
Topical imiquimod in the treatment of large facial keratoacanthomas. Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2012, Volume: 147, Issue:5 Topics: Adjuvants, Immunologic; Administration, Topical; Aged, 80 and over; Aminoquinolines; Face; Female; Humans; Imiquimod; Keratoacanthoma; Male	2012
Spontaneous regression of keratoacanthoma can be promoted by topical treatment with imiquimod cream. Journal of the European Academy of Dermatology and Venereology : JEADV, 2004, Volume: 18, Issue:5 Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Cheek; Diagnosis, Differential; Female; Humans; Imiquimod; Keratoacanthoma; Middle Aged; Skin Diseases	2004
Topical treatment of nasal keratoacanthoma. Plastic and reconstructive surgery, 2006, Volume: 117, Issue:7 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Keratoacanthoma; Middle Aged; Nose Neoplasms; Treatment Outcome	2006
Multiple keratoacanthomas as an untoward response to imiquimod therapy for actinic keratoses. Acta dermato-venereologica, 2006, Volume: 86, Issue:4 Topics: Adjuvants, Immunologic; Aminoquinolines; Carcinoma, Squamous Cell; Humans; Imiquimod; Keratoacanthoma; Keratosis; Male; Middle Aged; Skin Neoplasms; Ultraviolet Rays	2006
Check Program. Australian family physician, 2007, Volume: 36, Issue:8 Topics: Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Bowen's Disease; Humans; Imiquimod; Keratoacanthoma; Methotrexate	2007
Successful treatment of keratoacanthoma centrifugum marginatum with local application of imiquimod cream. International journal of dermatology, 2007, Volume: 46, Issue:12 Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aminoquinolines; Female; Humans; Imiquimod; Keratoacanthoma; Leg Dermatoses; Middle Aged	2007